期刊论文详细信息
Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders
Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis
Expert Review
Shyamal Das1  Brian J. Gates2 
[1] US Field Medical, Novartis Pharmaceuticals Corp, East Hanover, NJ.;Washington State University College of Pharmacy, PO Box 1495, Spokane WA.;
关键词: risedronate;    hip fracture;    osteoporosis;    bisphosphonate;    postmenopausal women;   
DOI  :  10.4137/CMAMD.S4092
来源: Sage Journals
PDF
【 授权许可】

CC BY-NC   
© 2012 SAGE Publications.

【 预 览 】
附件列表
Files Size Format View
RO202212200410780ZK.pdf 536KB PDF download
Table 1 285KB Table download
【 参考文献 】
  • [1]
  • [2]
  • [3]
  • [4]
  • [5]
  • [6]
  • [7]
  • [8]
  • [9]
  • [10]
  • [11]
  • [12]
  • [13]
  • [14]
  • [15]
  • [16]
  • [17]
  • [18]
  • [19]
  • [20]
  • [21]
  • [22]
  • [23]
  • [24]
  • [25]
  • [26]
  • [27]
  • [28]
  • [29]
  • [30]
  • [31]
  • [32]
  • [33]
  • [34]
  • [35]
  • [36]
  • [37]
  • [38]
  • [39]
  • [40]
  • [41]
  • [42]
  • [43]
  • [44]
  • [45]
  • [46]
  • [47]
  • [48]
  • [49]
  • [50]
  • [51]
  • [52]
  • [53]
  • [54]
  • [55]
  • [56]
  • [57]
  • [58]
  • [59]
  • [60]
  • [61]
  • [62]
  • [63]
  • [64]
  • [65]
  • [66]
  • [67]
  • [68]
  文献评价指标  
  下载次数:2次 浏览次数:0次